MMP2 and lung carcinoma: Notably, a recent study reported that combined treatment of Nef and cisplatin can significantly inhibit MMP-2 enzyme activity in human lung cancer cells, although treatment with Nef alone did not show significant effects (Sivalingam et al., 2017).